Our scientific advisory board plays an important role as we
aim to develop the best medicines possible from our
intellectual property. Our Scientific Advisory Board meets
periodically to discuss and evaluate potential opportunities
and guide our scientists as they work to develop new and
improved versions of our existing products.
Martine Rothblatt Ph.D., J.D., M.B.A.
Michael Benkowitz
James Edgemond
Paul A. Mahon, J.D.
Christopher Causey, M.B.A.
Raymond Dwek, C.B.E., F.R.S
Richard Giltner
Ray Kurzweil
Jan Malcolm
Linda Maxwell, M.D., M.B.A.
Nilda Mesa, J.D.
Judy Olian, Ph.D.
Christopher Patusky, J.D., M.G.A.
Louis Sullivan, M.D.
Tommy Thompson, J.D.